메뉴 건너뛰기




Volumn 10, Issue 6, 2011, Pages 899-921

Colorectal cancer vaccines in clinical trials

Author keywords

cancer; colon; colorectal; immune monitoring; immunotherapy; therapeutic; vaccine

Indexed keywords

ALLOGENEIC TUMOR CELL VACCINE; AUTOLOGOUS TUMOR CELL VACCINE; CANCER VACCINE; CARCINOEMBRYONIC ANTIGEN; CHORIONIC GONADOTROPIN BETA SUBUNIT; DENDRITIC CELL VACCINE; FLUOROURACIL; FOLINATE CALCIUM; FOLINIC ACID; HLA A2 ANTIGEN; HLA A24 ANTIGEN; INTERLEUKIN 2; IPILIMUMAB; IRINOTECAN; MONTANIDE ISA 51; MUCIN 1; MULTIDRUG RESISTANCE PROTEIN 3; PROTEIN KINASE LCK; PROTEIN P53; PROVENGE; RAS PROTEIN; SART1 ANTIGEN; SART3 ANTIGEN; SIALYL TN ANTIGEN; SURVIVIN; TUMOR ANTIGEN VACCINE; TUMOR CELL DERIVED VACCINE; UFT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN RECEPTOR;

EID: 79959545235     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.11.63     Document Type: Review
Times cited : (20)

References (139)
  • 3
    • 78049485263 scopus 로고    scopus 로고
    • Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
    • 10.1002/ijc.25516 Epub ahead of print
    • Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer DOI: 10.1002/ijc.25516 (2010) (Epub ahead of print
    • (2010) Int. J. Cancer
    • Ferlay, J.1    Shin, H.R.2    Bray, F.3    Forman, D.4    Mathers, C.5    Parkin, D.M.6
  • 4
    • 33144482991 scopus 로고    scopus 로고
    • Current strategies in previously untreated advanced colorectal cancer
    • Williston Park 727
    • Penland SK, Goldberg RM. Current strategies in previously untreated advanced colorectal cancer. Oncology (Williston Park) 18(6), 715-722, 727 (2004
    • (2004) Oncology , vol.18 , Issue.6 , pp. 715-722
    • Penland, S.K.1    Goldberg, R.M.2
  • 5
    • 21744436819 scopus 로고    scopus 로고
    • An overview of approaches to adjuvant therapy for colorectal cancer in the united states
    • Hobday TJ. An overview of approaches to adjuvant therapy for colorectal cancer in the United States. Clin. Colorectal Cancer 5(Suppl. 1), S11-S18 (2005
    • (2005) Clin. Colorectal Cancer , vol.5 , Issue.1
    • Hobday, T.J.1
  • 6
    • 13744251436 scopus 로고    scopus 로고
    • Systemic therapy for colorectal cancer
    • Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. N. Engl. J. Med. 352(5), 476-487 (2005
    • (2005) N. Engl. J. Med. , vol.352 , Issue.5 , pp. 476-487
    • Meyerhardt, J.A.1    Mayer, R.J.2
  • 7
    • 61349188341 scopus 로고    scopus 로고
    • Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer MRC CR07 and NCIC-CTG C016: A multicentre randomised trial
    • Sebag-Montefiore D, Stephens RJ, Steele R et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373(9666), 811-820 (2009
    • (2009) Lancet , vol.373 , Issue.9666 , pp. 811-820
    • Sebag-Montefiore, D.1    Stephens, R.J.2    Steele, R.3
  • 10
    • 84960949820 scopus 로고
    • Cancer: A biological approach III Viruses associated with neoplastic conditions IV practical applications
    • Burnet M. Cancer: a biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications. Br. Med. J. 1(5023), 841-847 (1957
    • (1957) Br. Med. J. , vol.1 , Issue.5023 , pp. 841-847
    • Burnet, M.1
  • 11
    • 0028936599 scopus 로고
    • Cancer risk after renal transplantation in the nordic countries 1964-1986
    • Birkeland SA, Storm HH, Lamm LU et al. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int. J. Cancer 60(2), 183-189 (1995
    • (1995) Int. J. Cancer , vol.60 , Issue.2 , pp. 183-189
    • Birkeland, S.A.1    Storm, H.H.2    Lamm, L.U.3
  • 12
    • 79151470865 scopus 로고    scopus 로고
    • Effects of chronic immunosuppression on long-term oncologic outcomes for colorectal cancer patients undergoing surgery
    • Khoury W, Lavery IC, Kiran RP. Effects of chronic immunosuppression on long-term oncologic outcomes for colorectal cancer patients undergoing surgery. Ann. Surg. 253(2), 323-327 (2010
    • (2010) Ann. Surg. , vol.253 , Issue.2 , pp. 323-327
    • Khoury, W.1    Lavery, I.C.2    Kiran, R.P.3
  • 14
    • 77955066199 scopus 로고    scopus 로고
    • Sipuleucel-T immunotherapy for castration-resistant prostate cancer
    • Kantoff PW, Higano CS, Shore ND et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N. Engl. J. Med. 363(5), 411-422 (2010
    • (2010) N. Engl. J. Med. , vol.363 , Issue.5 , pp. 411-422
    • Kantoff, P.W.1    Higano, C.S.2    Shore, N.D.3
  • 16
    • 78650801857 scopus 로고    scopus 로고
    • Sipuleucel-T: In metastatic castration-resistant prostate cancer
    • Plosker GL. Sipuleucel-T: in metastatic castration-resistant prostate cancer. Drugs 71(1), 101-108 (2011
    • (2011) Drugs , vol.71 , Issue.1 , pp. 101-108
    • Plosker, G.L.1
  • 17
    • 77954801079 scopus 로고    scopus 로고
    • Improved survival with ipilimumab in patients with metastatic melanoma
    • Hodi FS, O'Day SJ, McDermott DF et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363(8), 711-723 (2010
    • (2010) N. Engl. J. Med. , vol.363 , Issue.8 , pp. 711-723
    • Hodi, F.S.1    O'Day, S.J.2    McDermott, D.F.3
  • 19
    • 55949125601 scopus 로고    scopus 로고
    • Adoptive cell therapy for patients with metastatic melanoma: Evaluation of intensive myeloablative chemoradiation preparative regimens
    • Dudley ME, Yang JC, Sherry R et al. Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens. J. Clin. Oncol. 26(32), 5233-5239 (2008
    • (2008) J. Clin. Oncol. , vol.26 , Issue.32 , pp. 5233-5239
    • Dudley, M.E.1    Yang, J.C.2    Sherry, R.3
  • 20
    • 41149097574 scopus 로고    scopus 로고
    • Adoptive cell transfer: A clinical path to effective cancer immunotherapy
    • DOI 10.1038/nrc2355, PII NRC2355
    • Rosenberg SA, Restifo NP, Yang JC, Morgan RA, Dudley ME. Adoptive cell transfer: a clinical path to effective cancer immunotherapy. Nat. Rev. Cancer 8(4), 299-308 (2008 (Pubitemid 351430867)
    • (2008) Nature Reviews Cancer , vol.8 , Issue.4 , pp. 299-308
    • Rosenberg, S.A.1    Restifo, N.P.2    Yang, J.C.3    Morgan, R.A.4    Dudley, M.E.5
  • 21
    • 70350772293 scopus 로고    scopus 로고
    • Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia
    • Kenter GG, Welters MJ, Valentijn AR et al. Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia. N. Engl. J. Med. 361(19), 1838-1847 (2009
    • (2009) N. Engl. J. Med. , vol.361 , Issue.19 , pp. 1838-1847
    • Kenter, G.G.1    Welters, M.J.2    Valentijn, A.R.3
  • 22
    • 33748987908 scopus 로고    scopus 로고
    • Cancer despite immunosurveillance: Immunoselection and immunosubversion
    • DOI 10.1038/nri1936, PII NRI1936
    • Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat. Rev. Immunol. 6(10), 715-727 (2006 (Pubitemid 44453458)
    • (2006) Nature Reviews Immunology , vol.6 , Issue.10 , pp. 715-727
    • Zitvogel, L.1    Tesniere, A.2    Kroemer, G.3
  • 23
    • 78149488860 scopus 로고    scopus 로고
    • + B cells: The other tumor-infiltrating lymphocytes
    • + B cells: the other tumor-infiltrating lymphocytes. J. Immunol. 185(9), 4977-4982 (2010
    • (2010) J. Immunol. , vol.185 , Issue.9 , pp. 4977-4982
    • Nelson, B.H.1
  • 24
    • 40549140777 scopus 로고    scopus 로고
    • Therapeutic vaccines in cancer: Moving from immunomonitoring to immunoguiding
    • DOI 10.1586/14760584.7.1.1
    • van der Burg SH. Therapeutic vaccines in cancer: moving from immunomonitoring to immunoguiding. Expert Rev. Vaccines 7(1), 1-5 (2008 (Pubitemid 351357961)
    • (2008) Expert Review of Vaccines , vol.7 , Issue.1 , pp. 1-5
    • Van Der Burg, S.H.1
  • 25
    • 14844309609 scopus 로고    scopus 로고
    • Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: A prospective study of medical and economic benefits
    • DOI 10.1016/j.vaccine.2005.01.015
    • Uyl-de Groot CA, Vermorken JB, Hanna MG Jr et al. Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits. Vaccine 23(17-18), 2379-2387 (2005 (Pubitemid 40341488)
    • (2005) Vaccine , vol.23 , Issue.17-18 , pp. 2379-2387
    • Uyl-de Groot, C.A.1    Vermorken, J.B.2    Hanna Jr., M.G.3    Verboom, P.4    Groot, M.T.5    Bonsel, G.J.6    Meijer, C.J.L.M.7    Pinedo, H.M.8
  • 27
    • 18544386260 scopus 로고    scopus 로고
    • A Phase II study of active specific immunotherapy and 5-FU/Leucovorin as adjuvant therapy for stage III colon carcinoma
    • Baars A, Claessen AM, Wagstaff J et al. A Phase II study of active specific immunotherapy and 5-FU/Leucovorin as adjuvant therapy for stage III colon carcinoma. Br. J. Cancer 86(8), 1230-1234 (2002
    • (2002) Br. J. Cancer , vol.86 , Issue.8 , pp. 1230-1234
    • Baars, A.1    Claessen, A.M.2    Wagstaff, J.3
  • 30
    • 54849420913 scopus 로고    scopus 로고
    • Efficiency of adjuvant active specific immunization with newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: Results of a prospective randomized trial
    • Schulze T, Kemmner W, Weitz J, Wernecke KD, Schirrmacher V, Schlag PM. Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial. Cancer Immunol. Immunother. 58(1), 61-69 (2009
    • (2009) Cancer Immunol. Immunother , vol.58 , Issue.1 , pp. 61-69
    • Schulze, T.1    Kemmner, W.2    Weitz, J.3    Wernecke, K.D.4    Schirrmacher, V.5    Schlag, P.M.6
  • 35
    • 77949423735 scopus 로고    scopus 로고
    • Regulating functional cell fates in CD8 T cells
    • Shrikant PA, Rao R, Li Q et al. Regulating functional cell fates in CD8 T cells. Immunol. Res. 46(1-3), 12-22 (2010
    • (2010) Immunol. Res. , vol.46 , Issue.1-3 , pp. 12-22
    • Shrikant, P.A.1    Rao, R.2    Li, Q.3
  • 36
    • 59249097938 scopus 로고    scopus 로고
    • Clinical responses in patients with advanced colorectal cancer to a dendritic cell based vaccine
    • Burgdorf SK, Fischer A, Myschetzky PS et al. Clinical responses in patients with advanced colorectal cancer to a dendritic cell based vaccine. Oncol. Rep. 20(6), 1305-1311 (2008
    • (2008) Oncol. Rep. , vol.20 , Issue.6 , pp. 1305-1311
    • Burgdorf, S.K.1    Fischer, A.2    Myschetzky, P.S.3
  • 37
    • 73349131696 scopus 로고    scopus 로고
    • Clinical benefit of allogeneic melanoma cell lysate-pulsed autologous dendritic cell vaccine in MAGE-positive colorectal cancer patients
    • Toh HC, Wang WW, Chia WK et al. Clinical benefit of allogeneic melanoma cell lysate-pulsed autologous dendritic cell vaccine in MAGE-positive colorectal cancer patients. Clin. Cancer Res. 15(24), 7726-7736 (2009
    • (2009) Clin. Cancer Res. , vol.15 , Issue.24 , pp. 7726-7736
    • Toh, H.C.1    Wang, W.W.2    Chia, W.K.3
  • 40
    • 0036690395 scopus 로고    scopus 로고
    • Expression of melanoma antigen-encoding genes MAGE by common primers for MAGE-A1 to -A6 in colorectal carcinomas among Koreans
    • Park MS, Park JW, Jeon CH, Lee KD, Chang HK. Expression of melanoma antigen-encoding genes (MAGE) by common primers for MAGE-A1 to -A6 in colorectal carcinomas among Koreans. J. Korean Med. Sci. 17(4), 497-501 (2002
    • (2002) J. Korean Med. Sci. , vol.17 , Issue.4 , pp. 497-501
    • Park, M.S.1    Park, J.W.2    Jeon, C.H.3    Lee, K.D.4    Chang, H.K.5
  • 41
    • 16344385247 scopus 로고    scopus 로고
    • Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue
    • DOI 10.1158/1078-0432.CCR-04-1365
    • Li M, Yuan YH, Han Y et al. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue. Clin. Cancer Res. 11(5), 1809-1814 (2005 (Pubitemid 40471843)
    • (2005) Clinical Cancer Research , vol.11 , Issue.5 , pp. 1809-1814
    • Li, M.1    Yuan, Y.-H.2    Han, Y.3    Liu, Y.-X.4    Yan, L.5    Wang, Y.6    Gu, J.7
  • 42
    • 11844265528 scopus 로고    scopus 로고
    • Part I: Vaccines for solid tumours
    • DOI 10.1016/S1470-2045(04)01610-9, PII S1470204504016109
    • Mocellin S, Mandruzzato S, Bronte V, Lise M, Nitti D. Part I: vaccines for solid tumours. Lancet Oncol. 5(11), 681-689 (2004 (Pubitemid 40267853)
    • (2004) Lancet Oncology , vol.5 , Issue.11 , pp. 681-689
    • Mocellin, S.1    Mandruzzato, S.2    Bronte, V.3    Lise, M.4    Nitti, D.5
  • 44
    • 33846935228 scopus 로고    scopus 로고
    • Unique human tumor antigens: Immunobiology and use in clinical trials
    • Parmiani G, De Filippo A, Novellino L, Castelli C. Unique human tumor antigens: immunobiology and use in clinical trials. J. Immunol. 178(4), 1975-1979 (2007 (Pubitemid 46233392)
    • (2007) Journal of Immunology , vol.178 , Issue.4 , pp. 1975-1979
    • Parmiani, G.1    De Filippo, A.2    Novellino, L.3    Castelli, C.4
  • 45
    • 76149122520 scopus 로고    scopus 로고
    • 5T4-modified vaccinia Ankara: Progress in tumor-associated antigen-based immunotherapy
    • Amato RJ. 5T4-modified vaccinia Ankara: progress in tumor-associated antigen-based immunotherapy. Expert Opin. Biol. Ther. 10(2), 281-287 (2010
    • (2010) Expert Opin. Biol. Ther. , vol.10 , Issue.2 , pp. 281-287
    • Amato, R.J.1
  • 47
    • 0343938862 scopus 로고    scopus 로고
    • The use of HLA A2.1/p53 peptide tetramers to visualize the impact of self tolerance on the TCR repertoire
    • Hernandez J, Lee PP, Davis MM, Sherman LA. The use of HLA A2.1/p53 peptide tetramers to visualize the impact of self tolerance on the TCR repertoire. J. Immunol. 164(2), 596-602 (2000 (Pubitemid 30043678)
    • (2000) Journal of Immunology , vol.164 , Issue.2 , pp. 596-602
    • Hernandez, J.1    Lee, P.P.2    Davis, M.M.3    Sherman, L.A.4
  • 49
    • 61349184597 scopus 로고    scopus 로고
    • Induction of p53-specific immunity by a p53 synthetic long peptide vaccine in patients treated for metastatic colorectal cancer
    • Speetjens FM, Kuppen PJ, Welters MJ et al. Induction of p53-specific immunity by a p53 synthetic long peptide vaccine in patients treated for metastatic colorectal cancer. Clin. Cancer Res. 15(3), 1086-1095 (2009
    • (2009) Clin. Cancer Res. , vol.15 , Issue.3 , pp. 1086-1095
    • Speetjens, F.M.1    Kuppen, P.J.2    Welters, M.J.3
  • 51
    • 27744573098 scopus 로고    scopus 로고
    • The cooperation between two CD4 T cells induces tumor protective immunity in MUC.1 transgenic mice
    • Gerloni M, Castiglioni P, Zanetti M. The cooperation between two CD4 T cells induces tumor protective immunity in MUC.1 transgenic mice. J. Immunol. 175(10), 6551-6559 (2005 (Pubitemid 41598897)
    • (2005) Journal of Immunology , vol.175 , Issue.10 , pp. 6551-6559
    • Gerloni, M.1    Castiglioni, P.2    Zanetti, M.3
  • 52
    • 33847412258 scopus 로고    scopus 로고
    • Lack of effective MUC1 tumor antigen-specific immunity in MUC1-transgenic mice results from a Th/T regulatory cell imbalance that can be corrected by adoptive transfer of wild-type Th cells
    • Turner MS, Cohen PA, Finn OJ. Lack of effective MUC1 tumor antigen-specific immunity in MUC1-transgenic mice results from a Th/T regulatory cell imbalance that can be corrected by adoptive transfer of wild-type Th cells. J. Immunol. 178(5), 2787-2793 (2007 (Pubitemid 46333156)
    • (2007) Journal of Immunology , vol.178 , Issue.5 , pp. 2787-2793
    • Turner, M.S.1    Cohen, P.A.2    Finn, O.J.3
  • 53
    • 53449093328 scopus 로고    scopus 로고
    • Targeting of antigens to B cells augments antigen-specific T-cell responses and breaks immune tolerance to tumor-associated antigen MUC1
    • Ding C, Wang L, Marroquin J, Yan J. Targeting of antigens to B cells augments antigen-specific T-cell responses and breaks immune tolerance to tumor-associated antigen MUC1. Blood 112(7), 2817-2825 (2008
    • (2008) Blood , vol.112 , Issue.7 , pp. 2817-2825
    • Ding, C.1    Wang, L.2    Marroquin, J.3    Yan, J.4
  • 54
    • 68149166302 scopus 로고    scopus 로고
    • Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice
    • Ryan SO, Vlad AM, Islam K, Gariepy J, Finn OJ. Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice. Biol. Chem. 390(7), 611-618 (2009
    • (2009) Biol. Chem. , vol.390 , Issue.7 , pp. 611-618
    • Ryan, S.O.1    Vlad, A.M.2    Islam, K.3    Gariepy, J.4    Finn, O.J.5
  • 55
    • 0036812719 scopus 로고    scopus 로고
    • Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes
    • DOI 10.1034/j.1600-065X.2002.18816.x
    • Melief CJ, van der Burg SH, Toes RE, Ossendorp F, Offringa R. Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes. Immunol. Rev. 188, 177-182 (2002 (Pubitemid 35398875)
    • (2002) Immunological Reviews , vol.188 , pp. 177-182
    • Melief, C.J.M.1    Van Der Burg, S.H.2    Toes, R.E.M.3    Ossendorp, F.4    Offringa, R.5
  • 56
    • 42549138499 scopus 로고    scopus 로고
    • Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines
    • DOI 10.1038/nrc2373, PII NRC2373
    • Melief CJ, van der Burg SH. Immunotherapy of established (pre) malignant disease by synthetic long peptide vaccines. Nat. Rev. Cancer 8(5), 351-360 (2008 (Pubitemid 351589701)
    • (2008) Nature Reviews Cancer , vol.8 , Issue.5 , pp. 351-360
    • Melief, C.J.M.1    Van Der Burg, S.H.2
  • 60
    • 70349766001 scopus 로고    scopus 로고
    • Immunological evaluation of personalized peptide vaccination in combination with UFT and UZEL for metastatic colorectal carcinoma patients
    • Hattori T, Mine T, Komatsu N et al. Immunological evaluation of personalized peptide vaccination in combination with UFT and UZEL for metastatic colorectal carcinoma patients. Cancer Immunol. Immunother. 58(11), 1843-1852 (2009
    • (2009) Cancer Immunol. Immunother. , vol.58 , Issue.11 , pp. 1843-1852
    • Hattori, T.1    Mine, T.2    Komatsu, N.3
  • 64
    • 0035992254 scopus 로고    scopus 로고
    • Active specific immunotherapy with a β-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: Antibody response is associated with improved survival
    • Moulton HM, Yoshihara PH, Mason DH, Iversen PL, Triozzi PL. Active specific immunotherapy with a b-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival. Clin. Cancer Res. 8(7), 2044-2051 (2002 (Pubitemid 34753572)
    • (2002) Clinical Cancer Research , vol.8 , Issue.7 , pp. 2044-2051
    • Moulton, H.M.1    Yoshihara, P.H.2    Mason, D.H.3    Iversen, P.L.4    Triozzi, P.L.5
  • 65
    • 0030000007 scopus 로고    scopus 로고
    • A phase I trial of a synthetic mucin peptide vaccine: Induction of specific immune reactivity in patients with adenocarcinoma
    • DOI 10.1006/jsre.1996.0264
    • Goydos JS, Elder E, Whiteside TL, Finn OJ, Lotze MT. A Phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma. J. Surg. Res. 63(1), 298-304 (1996 (Pubitemid 26197209)
    • (1996) Journal of Surgical Research , vol.63 , Issue.1 , pp. 298-304
    • Goydos, J.S.1    Elder, E.2    Whiteside, T.L.3    Finn, O.J.4    Lotze, M.T.5
  • 74
    • 51049083164 scopus 로고    scopus 로고
    • Combination chemotherapy and ALVAC-CEA/B7.1 vaccine in patients with metastatic colorectal cancer
    • Kaufman HL, Lenz HJ, Marshall J et al. Combination chemotherapy and ALVAC-CEA/B7.1 vaccine in patients with metastatic colorectal cancer. Clin. Cancer Res. 14(15), 4843-4849 (2008
    • (2008) Clin. Cancer Res. , vol.14 , Issue.15 , pp. 4843-4849
    • Kaufman, H.L.1    Lenz, H.J.2    Marshall, J.3
  • 75
    • 0033766694 scopus 로고    scopus 로고
    • Phase I clinical trial of a recombinant canarypoxvirus ALVAC vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule
    • Horig H, Lee DS, Conkright W et al. Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule. Cancer Immunol. Immunother. 49(9), 504-514 (2000
    • (2000) Cancer Immunol. Immunother. , vol.49 , Issue.9 , pp. 504-514
    • Horig, H.1    Lee, D.S.2    Conkright, W.3
  • 77
    • 0033973608 scopus 로고    scopus 로고
    • Specific cytolytic T-cell responses to human CEA from patients immunized with recombinant avipox-CEA vaccine
    • Zhu MZ, Marshall J, Cole D, Schlom J, Tsang KY. Specific cytolytic T-cell responses to human CEA from patients immunized with recombinant avipox-CEA vaccine. Clin. Cancer Res. 6(1), 24-33 (2000 (Pubitemid 30064972)
    • (2000) Clinical Cancer Research , vol.6 , Issue.1 , pp. 24-33
    • Zhu, M.1    Marshall, J.2    Cole, D.3    Schlom, J.4    Tsang, K.Y.5
  • 78
    • 0034551730 scopus 로고    scopus 로고
    • Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses
    • Marshall JL, Hoyer RJ, Toomey MA et al. Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses. J. Clin. Oncol. 18(23), 3964-3973 (2000
    • (2000) J. Clin. Oncol. , vol.18 , Issue.23 , pp. 3964-3973
    • Marshall, J.L.1    Hoyer, R.J.2    Toomey, M.A.3
  • 80
    • 0037966117 scopus 로고    scopus 로고
    • Immunization of colorectal carcinoma patients with a recombinant canarypox virus expressing the tumor antigen Ep-CAM/KSA (ALVAC-KSA) and granulocyte macrophage colony-stimulating factor induced a tumor-specific cellular immune response
    • Ullenhag GJ, Frodin JE, Mosolits S et al. Immunization of colorectal carcinoma patients with a recombinant canarypox virus expressing the tumor antigen Ep-CAM/KSA (ALVAC-KSA) and granulocyte macrophage colony-stimulating factor induced a tumor-specific cellular immune response. Clin. Cancer Res. 9(7), 2447-2456 (2003 (Pubitemid 36849588)
    • (2003) Clinical Cancer Research , vol.9 , Issue.7 , pp. 2447-2456
    • Ullenhag, G.J.1    Frodin, J.-E.2    Mosolits, S.3    Kiaii, S.4    Hassan, M.5    Bonnet, M.C.6    Moingeon, P.7    Mellstedt, H.8    Rabbani, H.9
  • 83
    • 33745223435 scopus 로고    scopus 로고
    • Vaccination of colorectal cancer patients with modified vaccinia ankara delivering the tumor antigen 5T4 TroVax induces immune responses which correlate with disease control: A Phase I/II trial
    • 11 Pt 1
    • Harrop R, Connolly N, Redchenko I et al. Vaccination of colorectal cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease control: a Phase I/II trial. Clin. Cancer Res. 12(11 Pt 1), 3416-3424 (2006
    • (2006) Clin. Cancer Res. , vol.12 , pp. 3416-3424
    • Harrop, R.1    Connolly, N.2    Redchenko, I.3
  • 85
    • 68549110430 scopus 로고    scopus 로고
    • Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax MVA-5T4
    • Elkord E, Dangoor A, Burt DJ et al. Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4Cancer Immunol. Immunother. 58(10), 1657-1667 (2009
    • (2009) Cancer Immunol. Immunother. , vol.58 , Issue.10 , pp. 1657-1667
    • Elkord, E.1    Dangoor, A.2    Burt, D.J.3
  • 86
    • 67650136139 scopus 로고    scopus 로고
    • An MVA-based vaccine targeting the oncofetal antigen 5T4 in patients undergoing surgical resection of colorectal cancer liver metastases
    • Elkord E, Dangoor A, Drury NL et al. An MVA-based vaccine targeting the oncofetal antigen 5T4 in patients undergoing surgical resection of colorectal cancer liver metastases. J. Immunother. 31(9), 820-829 (2008
    • (2008) J. Immunother. , vol.31 , Issue.9 , pp. 820-829
    • Elkord, E.1    Dangoor, A.2    Drury, N.L.3
  • 87
    • 59449090966 scopus 로고    scopus 로고
    • Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer
    • Zhang T, Herlyn D. Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer. Cancer Immunol. Immunother. 58(4), 475-492 (2009
    • (2009) Cancer Immunol. Immunother. , vol.58 , Issue.4 , pp. 475-492
    • Zhang, T.1    Herlyn, D.2
  • 88
    • 77954899030 scopus 로고    scopus 로고
    • Phase I study of single-agent anti-programmed death-1 MDX-1106 in refractory solid tumors: Safety clinical activity pharmacodynamics and immunologic correlates
    • Brahmer JR, Drake CG, Wollner I et al. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. J. Clin. Oncol. 28(19), 3167-3175 (2010
    • (2010) J. Clin. Oncol. , vol.28 , Issue.19 , pp. 3167-3175
    • Brahmer, J.R.1    Drake, C.G.2    Wollner, I.3
  • 90
    • 70249141312 scopus 로고    scopus 로고
    • Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients a Phase II trial
    • Leffers N, Lambeck AJ, Gooden MJ et al. Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a Phase II trial. Int. J. Cancer 125(9), 2104-2113 (2009
    • (2009) Int. J. Cancer , vol.125 , Issue.9 , pp. 2104-2113
    • Leffers, N.1    Lambeck, A.J.2    Gooden, M.J.3
  • 91
    • 0035113705 scopus 로고    scopus 로고
    • Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients
    • Knutson KL, Schiffman K, Disis ML. Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients. J. Clin. Invest. 107(4), 477-484 (2001 (Pubitemid 32167994)
    • (2001) Journal of Clinical Investigation , vol.107 , Issue.4 , pp. 477-484
    • Knutson, K.L.1    Schiffman, K.2    Disis, M.L.3
  • 93
    • 22144439081 scopus 로고    scopus 로고
    • Tumor antigen-specific T helper cells in cancer immunity and immunotherapy
    • DOI 10.1007/s00262-004-0653-2
    • Knutson KL, Disis ML. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunol. Immunother. 54(8), 721-728 (2005 (Pubitemid 40977140)
    • (2005) Cancer Immunology, Immunotherapy , vol.54 , Issue.8 , pp. 721-728
    • Knutson, K.L.1    Disis, M.L.2
  • 95
    • 48149090897 scopus 로고    scopus 로고
    • Detection and functional analysis of tumor infiltrating T-lymphocytes TIL in liver metastases from colorectal cancer
    • Wagner P, Koch M, Nummer D et al. Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer. Ann. Surg. Oncol. 15(8), 2310-2317 (2008
    • (2008) Ann. Surg. Oncol. , vol.15 , Issue.8 , pp. 2310-2317
    • Wagner, P.1    Koch, M.2    Nummer, D.3
  • 96
    • 70449360735 scopus 로고    scopus 로고
    • Antigen-specific tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma
    • Bonertz A, Weitz J, Pietsch DH et al. Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma. J. Clin. Invest 119(11), 3311-3321 (2009
    • (2009) J. Clin. Invest , vol.119 , Issue.11 , pp. 3311-3321
    • Bonertz, A.1    Weitz, J.2    Pietsch, D.H.3
  • 97
    • 25144476050 scopus 로고    scopus 로고
    • ABCE1 a member of ATP-binding cassette transporter gene encodes peptides capable of inducing HLA-A2-restricted and tumor-reactive cytotoxic T lymphocytes in colon cancer patients
    • Shichijo S, Ishihara Y, Azuma K et al. ABCE1, a member of ATP-binding cassette transporter gene, encodes peptides capable of inducing HLA-A2-restricted and tumor-reactive cytotoxic T lymphocytes in colon cancer patients. Oncol. Rep. 13(5), 907-913 (2005
    • (2005) Oncol. Rep. , vol.13 , Issue.5 , pp. 907-913
    • Shichijo, S.1    Ishihara, Y.2    Azuma, K.3
  • 99
    • 33745653128 scopus 로고    scopus 로고
    • Decoding hereditary colorectal cancer
    • DOI 10.1056/NEJMe068110
    • Boland CR. Decoding hereditary colorectal cancer. N. Engl. J. Med. 354(26), 2815-2817 (2006 (Pubitemid 43974200)
    • (2006) New England Journal of Medicine , vol.354 , Issue.26 , pp. 2815-2817
    • Boland, C.R.1
  • 100
    • 33748328364 scopus 로고    scopus 로고
    • Hereditary non-polyposis colerectal cancer: The rise and fall of a confusing term
    • Jass JR. Hereditary non-polyposis colorectal cancer: the rise and fall of a confusing term. World J. Gastroenterol. 12(31), 4943-4950 (2006 (Pubitemid 44323261)
    • (2006) World Journal of Gastroenterology , vol.12 , Issue.31 , pp. 4943-4950
    • Jass, J.R.1
  • 102
    • 0027285475 scopus 로고
    • Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis
    • DOI 10.1038/363558a0
    • Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363(6429), 558-561 (1993 (Pubitemid 23186645)
    • (1993) Nature , vol.363 , Issue.6429 , pp. 558-561
    • Ionov, Y.1    Peinado, M.A.2    Malkhosyan, S.3    Shibata, D.4    Perucho, M.5
  • 103
    • 0027314411 scopus 로고
    • Microsatellite instability in cancer of the proximal colon
    • Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 260(5109), 816-819 (1993 (Pubitemid 23167612)
    • (1993) Science , vol.260 , Issue.5109 , pp. 816-819
    • Thibodeau, S.N.1    Bren, G.2    Schaid, D.3
  • 104
    • 0029112453 scopus 로고
    • Microsatellite instability in ovarian neoplasms
    • King BL, Carcangiu ML, Carter D et al. Microsatellite instability in ovarian neoplasms. Br. J. Cancer 72(2), 376-382 (1995
    • (1995) Br. J. Cancer , vol.72 , Issue.2 , pp. 376-382
    • King, B.L.1    Carcangiu, M.L.2    Carter, D.3
  • 106
    • 0029156945 scopus 로고
    • Microsatellite instability in adenocarcinomas of the upper gastrointestinal tract relation to clinicopathological data and family history
    • Keller G, Rotter M, Vogelsang H et al. Microsatellite instability in adenocarcinomas of the upper gastrointestinal tract. Relation to clinicopathological data and family history. Am. J. Pathol. 147(3), 593-600 (1995
    • (1995) Am. J. Pathol. , vol.147 , Issue.3 , pp. 593-600
    • Keller, G.1    Rotter, M.2    Vogelsang, H.3
  • 107
    • 0032542364 scopus 로고    scopus 로고
    • Genetic instabilities in human cancers
    • DOI 10.1038/25292
    • Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 396(6712), 643-649 (1998 (Pubitemid 29003936)
    • (1998) Nature , vol.396 , Issue.6712 , pp. 643-649
    • Lengauer, C.1    Kinzler, K.W.2    Vogelstein, B.3
  • 108
    • 0035171887 scopus 로고    scopus 로고
    • Different mechanisms in the tumorigenesis of proximal and distal colon cancers
    • DOI 10.1097/00001622-200101000-00013
    • Lindblom A. Different mechanisms in the tumorigenesis of proximal and distal colon cancers. Curr. Opin. Oncol. 13(1), 63-69 (2001 (Pubitemid 32060047)
    • (2001) Current Opinion in Oncology , vol.13 , Issue.1 , pp. 63-69
    • Lindblom, A.1
  • 111
    • 48549099797 scopus 로고    scopus 로고
    • Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers
    • Speetjens FM, Kuppen PJ, Morreau H, van der Burg SH. Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers. Gastroenterology 135(2), 711-712 (2008
    • (2008) Gastroenterology , vol.135 , Issue.2 , pp. 711-712
    • Speetjens, F.M.1    Kuppen, P.J.2    Morreau, H.3    Van Der Burg, S.H.4
  • 112
    • 63849224217 scopus 로고    scopus 로고
    • +CD25+Foxp3+ suppressive T cells in colorectal cancer tissue
    • +CD25+Foxp3+ suppressive T cells in colorectal cancer tissue. Gut 58(4), 520-529 (2009
    • (2009) Gut. , vol.58 , Issue.4 , pp. 520-529
    • Chaput, N.1    Louafi, S.2    Bardier, A.3
  • 113
    • 77955725489 scopus 로고    scopus 로고
    • Accumulation of Foxp3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients
    • Deng L, Zhang H, Luan Y et al. Accumulation of Foxp3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients. Clin. Cancer Res. 16(16), 4105-4112 (2010
    • (2010) Clin. Cancer Res. , vol.16 , Issue.16 , pp. 4105-4112
    • Deng, L.1    Zhang, H.2    Luan, Y.3
  • 114
    • 77950468866 scopus 로고    scopus 로고
    • + T/FOXP3 + cell ratio is a predictive marker for survival in patients with colorectal cancer
    • + T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer. Cancer Immunol. Immunother. 59(5), 653-661 (2010
    • (2010) Cancer Immunol. Immunother. , vol.59 , Issue.5 , pp. 653-661
    • Suzuki, H.1    Chikazawa, N.2    Tasaka, T.3
  • 115
    • 33846913897 scopus 로고    scopus 로고
    • Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance
    • Zhou G, Levitsky HI. Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance. J. Immunol. 178(4), 2155-2162 (2007 (Pubitemid 46233413)
    • (2007) Journal of Immunology , vol.178 , Issue.4 , pp. 2155-2162
    • Zhou, G.1    Levitsky, H.I.2
  • 116
    • 77955411096 scopus 로고    scopus 로고
    • Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses
    • USA
    • Welters MJ, Kenter GG, de Vos van Steenwijk PJ et al. Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses. Proc. Natl Acad. Sci. USA 107(26), 11895-11899 (2010
    • (2010) Proc. Natl. Acad. Sci. , vol.107 , Issue.26 , pp. 11895-11899
    • Welters, M.J.1    Kenter, G.G.2    De Vos Van Steenwijk, P.J.3
  • 117
    • 43449101175 scopus 로고    scopus 로고
    • Tumor-specific regulatory T cells in cancer patients
    • Piersma SJ, Welters MJ, van der Burg SH. Tumor-specific regulatory T cells in cancer patients. Hum. Immunol. 69(4-5), 241-249 (2008
    • (2008) Hum. Immunol. , vol.69 , Issue.4-5 , pp. 241-249
    • Piersma, S.J.1    Welters, M.J.2    Van Der Burg, S.H.3
  • 119
    • 77958056009 scopus 로고    scopus 로고
    • Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: A Phase I/II study in metastatic melanoma patients
    • Jacobs JF, Punt CJ, Lesterhuis WJ et al. Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a Phase I/II study in metastatic melanoma patients. Clin. Cancer Res. 16(20), 5067-5078 (2010
    • (2010) Clin. Cancer Res. , vol.16 , Issue.20 , pp. 5067-5078
    • Jacobs, J.F.1    Punt, C.J.2    Lesterhuis, W.J.3
  • 120
    • 50949115267 scopus 로고    scopus 로고
    • Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines
    • Morse MA, Hobeika AC, Osada T et al. Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines. Blood 112(3), 610-618 (2008
    • (2008) Blood , vol.112 , Issue.3 , pp. 610-618
    • Morse, M.A.1    Hobeika, A.C.2    Osada, T.3
  • 122
  • 123
    • 65549133014 scopus 로고    scopus 로고
    • Coordination of intratumoral immune reaction and human colorectal cancer recurrence
    • Camus M, Tosolini M, Mlecnik B et al. Coordination of intratumoral immune reaction and human colorectal cancer recurrence. Cancer Res. 69(6), 2685-2693 (2009
    • (2009) Cancer Res. , vol.69 , Issue.6 , pp. 2685-2693
    • Camus, M.1    Tosolini, M.2    Mlecnik, B.3
  • 125
  • 127
    • 38049000452 scopus 로고    scopus 로고
    • Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy
    • Buckanovich RJ, Facciabene A, Kim S et al. Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. Nat. Med. 14(1), 28-36 (2008
    • (2008) Nat. Med. , vol.14 , Issue.1 , pp. 28-36
    • Buckanovich, R.J.1    Facciabene, A.2    Kim, S.3
  • 129
    • 77949780426 scopus 로고    scopus 로고
    • Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer
    • Mlecnik B, Tosolini M, Charoentong P et al. Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer. Gastroenterology 138(4), 1429-1440 (2010
    • (2010) Gastroenterology , vol.138 , Issue.4 , pp. 1429-1440
    • Mlecnik, B.1    Tosolini, M.2    Charoentong, P.3
  • 130
    • 77957273591 scopus 로고    scopus 로고
    • Improved endpoints for cancer immunotherapy trials
    • Hoos A, Eggermont AM, Janetzki S et al. Improved endpoints for cancer immunotherapy trials. J. Natl Cancer Inst. 102(18), 1388-1397 (2010
    • (2010) J. Natl. Cancer Inst. , vol.102 , Issue.18 , pp. 1388-1397
    • Hoos, A.1    Eggermont, A.M.2    Janetzki, S.3
  • 133
    • 68549133403 scopus 로고    scopus 로고
    • Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the cancer vaccine consortium
    • Britten CM, Janetzki S, Ben-Porat L et al. Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium. Cancer Immunol. Immunother. 58(10), 1701-1713 (2009
    • (2009) Cancer Immunol. Immunother. , vol.58 , Issue.10 , pp. 1701-1713
    • Britten, C.M.1    Janetzki, S.2    Ben-Porat, L.3
  • 134
    • 73149092567 scopus 로고    scopus 로고
    • Guidelines for the evaluation of immune therapy activity in solid tumors: Immune-related response criteria
    • Wolchok JD, Hoos A, O'Day S et al. Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria. Clin. Cancer Res. 15(23), 7412-7420 (2009
    • (2009) Clin. Cancer Res. , vol.15 , Issue.23 , pp. 7412-7420
    • Wolchok, J.D.1    Hoos, A.2    O'Day, S.3
  • 135
    • 57849117384 scopus 로고    scopus 로고
    • New response evaluation criteria in solid tumours: Revised recist guideline version 1.1
    • Eisenhauer EA, Therasse P, Bogaerts J et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1Eur. J. Cancer 45(2), 228-247 (2009
    • (2009) Eur. J. Cancer , vol.45 , Issue.2 , pp. 228-247
    • Eisenhauer, E.A.1    Therasse, P.2    Bogaerts, J.3
  • 137
    • 52649175424 scopus 로고    scopus 로고
    • New response criteria proposed for immunotherapies
    • Tuma RS. New response criteria proposed for immunotherapies. J. Natl Cancer Inst. 100(18), 1280-1281 (2008
    • (2008) J. Natl. Cancer Inst. , vol.100 , Issue.18 , pp. 1280-1281
    • Tuma, R.S.1
  • 138
    • 70350769383 scopus 로고    scopus 로고
    • Changes in cytokine and biomarker blood levels in patients with colorectal cancer during dendritic cell-based vaccination
    • Burgdorf SK, Claesson MH, Nielsen HJ, Rosenberg J. Changes in cytokine and biomarker blood levels in patients with colorectal cancer during dendritic cell-based vaccination. Acta Oncol. 48(8), 1157-1164 (2009
    • (2009) Acta Oncol. , vol.48 , Issue.8 , pp. 1157-1164
    • Burgdorf, S.K.1    Claesson, M.H.2    Nielsen, H.J.3    Rosenberg, J.4
  • 139
    • 12944325331 scopus 로고    scopus 로고
    • A listing of human tumor antigens recognized by T cells: March 2004 update
    • DOI 10.1007/s00262-004-0560-6
    • Novellino L, Castelli C, Parmiani G. A listing of human tumor antigens recognized by T cells: March 2004 update. Cancer Immunol. Immunother. 54(3), 187-207 (2005). (Pubitemid 40174238)
    • (2005) Cancer Immunology, Immunotherapy , vol.54 , Issue.3 , pp. 187-207
    • Novellino, L.1    Castelli, C.2    Parmiani, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.